Volume 23, Issue 4

The role of scientific experts in making public policy has rarely been as controversial as it has been during the COVID-19 pandemic. From the first public health containment strategies to the development and rollout of the vaccines, governmental authorities have claimed to rely on the “science,” citing an array of scientists and physicians, most of …

The Food and Drug Administration (“FDA”) continues to balance two seemingly competing goals: protecting the public from unsafe treatments and increasing the public’s access to treatments. While tensions between the goals of protection and access have ostensibly skyrocketed since the beginning of the COVID-19 global pandemic, these tensions have, in fact, been long-standing since the …

During the COVID-19 pandemic, for the first time, a significant minority of states passed laws limiting or outright prohibiting vaccines mandates. The laws varied greatly in what they covered, the way they addressed the issue, and their intended results. This Article provides a detailed overview of these mandate bans. Consequently, this Article demonstrates that most …

This Article explores the intertwined topics of hesitancy and trust towards vaccines. The Article traces the evolution of antivaccine sentiments, their consolidation into organized movements, and their recent evolution, as vaccine misinformation and disinformation circulate with unprecedented ease through digital channels. The Article then examines selected legal and policy interventions that have been used to …

Before 1980, the right to own the patent on any invention researched and developed under a federal funding agreement typically went to the federal agency that provided the funding. The Patent and Trademark Law Amendments Act of 1980, or Bayh-Dole Act, reorganized this framework by presumptively granting the ownership rights of any such patents to …